Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutations

BACKGROUND: Chemotherapy remains the standard care for HER2 mutated advanced non-small cell lung cancer (NSCLC) even though several targeted drugs showed promising results in preliminary stages. This study aimed to investigate the association of mutation variants with clinical features and the effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shuo, Wang, Yan, Zhao, Chao, Li, Xuefei, Liu, Qian, Mao, Shiqi, Liu, Yiwei, Yu, Xiaofei, Wang, Wanying, Tian, Qinrun, Pan, Yingying, Xiong, Anwen, Chen, Bin, Gao, Guanghui, Li, Wei, He, Yayi, Wu, Fengying, Chen, Xiaoxia, Su, Chunxia, Ren, Shengxiang, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947396/
https://www.ncbi.nlm.nih.gov/pubmed/33718019
http://dx.doi.org/10.21037/tlcr-20-559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947396/
https://www.ncbi.nlm.nih.gov/pubmed/33718019
http://dx.doi.org/10.21037/tlcr-20-559

Ejemplares similares